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Background: Age-related muscle wasting has been strongly implicated with falls and fractures in the elderly, but it
has also been associated with cognitive decline and dementia. Progressive resistance training (PRT) and adequate
dietary protein are recognised as important contributors to the maintenance of muscle health and function in older
adults. However, both factors also have the potential to improve brain function and prevent cognitive decline via
several pathways, including the regulation of various growth and neurotrophic factors [insulin-like growth factor-1
(IGF-1)]; brain-derived growth factor (BDNF)] and/or the modulation of systemic inflammation. The primary aim of
this study is to investigate whether a modest increase in dietary protein achieved through the consumption of lean
red meat three days per week, when combined with PRT, can enhance muscle mass, size and strength and cognitive
function in community-dwelling older people.
Methods/Design: The study design is a 48-week randomised controlled trial consisting of a 24-week intervention with
a 24-week follow-up. Men and women (n=152) aged 65 years and over residing in the community will be randomly
allocated to: 1) PRT and provided with 220 g (raw weight) of lean red meat to be cooked and divided into two 80 g
servings on each of the three days that they complete their exercise session, or 2) control PRT in which participants will
be provided with and advised to consume ≥1 serving (~1/2 cup) of rice and/or pasta or 1 medium potato on each of
the three training days. The primary outcome measures will be muscle mass, size and strength and cognitive function.
Secondary outcomes will include changes in: muscle function, neural health (corticospinal excitability and inhibition
and voluntary activation), serum IGF-1 and BDNF, adipokines and inflammatory markers, fat mass and inter-/intra-
muscular fat, blood pressure, lipids and health-related quality of life. All outcome measures will be assessed at baseline
and 24 weeks, with the exception of cognitive function and the various neurobiological and inflammatory markers
which will also be assessed at week 12.
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Discussion: The findings from this study will provide important new information on whether a modest increase in
dietary protein achieved through the ingestion of lean red meat can enhance the effects of PRT on muscle mass, size
and strength as well as cognitive function in community-dwelling older adults. If successful, the findings will form the
basis for more precise exercise and nutrition guidelines for the management and prevention of age-related changes in
muscle and neural health and cognitive function in the elderly.
Trial registration: Australian New Zealand Clinical Trials Registry: ACTRN12613001153707. Date registered 16th
October, 2013.
Keywords: Red meat, Progressive resistance training, Muscle, Cognition, Older adults, Randomised controlled trial,
Study protocolBackground
Age-related loss in muscle mass, strength and function,
which has been termed sarcopenia, has been linked to a
range of common chronic diseases, including an in-
creased risk for falls and fractures [1–3]. Although there
is no single cause of sarcopenia, physical inactivity, inad-
equate nutrition and age-related reductions in circulating
sex steroids, growth factors and vitamin D, and concomi-
tant increases in pro-inflammatory cytokines such as
interleukin-6 (IL-6), C-reactive protein (CRP) and tumor
necrosis factor-alpha (TNF-α), have all been impli-
cated [2, 4]. There is also strong evidence that de-
mentia and related cognitive deficits in older people,
particularly deficits in executive function such as the
ability to concentrate, to attend selectively, multi-task
and to plan and strategize, are associated with both
risk factors for falls [e.g., postural instability, impaired
gait, reduced ability to perform activities of daily liv-
ing (ADL)] as well as future falls [5]. Other studies
have also reported that low muscle mass and strength
and muscle loss are associated with cognitive impair-
ment [6–8] and brain atrophy [9]. Thus, identifying
interventions that can optimize muscle mass, strength
and function, and improve cognitive function are
likely to provide the greatest benefits in terms of en-
suring that older adults can live independently and
relatively disease and disability free into old age.
Progressive resistance training (PRT) is promoted as
one of the few lifestyle approaches that can significantly
increase muscle strength, mass and size, but there re-
mains considerable heterogeneity in the skeletal muscle
responses to PRT in older adults [10, 11]. For muscle
hypertrophy to occur there must be a net increase in
muscle protein balance, that is, muscle protein synthesis
(MPS) must exceed muscle protein breakdown (MPB).
PRT can stimulate MPS above resting levels, but MPB
also rises such that net protein balance remains negative
in the fasted state [12]. While the provision of protein
(amino acids) post-exercise can overcome this imbalance
and result in a net positive protein balance, the anabolic
sensitivity of skeletal muscle to protein appears to beblunted with ageing [12]. As a result, it has been sug-
gested that older adults require a higher dose of protein
to maximise MPS and promote muscle hypertrophy in
response to PRT [12, 13]. Although the optimal dose of
protein needed to enhance the anabolic response to PRT
in older adults is not known, there is some evidence that
a daily protein intake >1.2 to 1.5 g/kg body weight or
20–40 g of high quality protein ingested following PRT
can promote MPS and muscle hypertrophy [13–16].
While most previous studies have focused on the effects
of milk (whey and casein) and soy protein, red meat is
another rich source of protein that contains complete
and balanced proportions of all eight essential amino
acids, and has been shown to promote MPS at rest and
following PRT in older adults and the elderly [17–20].
For instance, it has been shown that ingestion of a 113 g
(moderate) serving of beef (30 g protein) produced a 50 %
increase in MPS [18], with no further gains following the
ingestion of a larger 340 g serving (90 g protein) [20]. In a
recent 4-month randomised controlled trial (RCT) in
women aged 60 years and over, we found that ingestion of
two ~80 g servings of cooked lean red meat on most days
of the week enhanced the effects of PRT on muscle mass,
strength and serum insulin-like growth factor-1 (IGF-1)
and reduced inflammation [serum IL-6]; there were no ad-
verse effects on blood pressure, lipids or kidney function
[15]. Despite these positive findings, promoting daily con-
sumption of red meat is not consistent with the current
Australian Dietary Guidelines [21]. Thus further research
is needed to determine whether less frequent consump-
tion (e.g., an intake consistent with current dietary guide-
lines of no more than 455 g per week of cooked lean red
meat) is equally effective when consumed in combination
with exercise.
In addition to preserving muscle health in older
people, recent attention has focused on identifying strat-
egies to attenuate age-related cognitive declines as this
has been identified as a key risk factor associated with
falls and disability in the elderly [22], and precedes the
development of dementia and Alzheimer’s disease [23].
Globally the prevalence of dementia is estimated to
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around 115 million people by 2050, with many more
people having some degree of cognitive impairment [24].
Currently there are no disease modifying pharmaco-
logical treatments to cure or delay the progression to de-
mentia. However, regular exercise, including aerobic
training, PRT or the combination, has been recognised
as promising strategies that can induce a cascade of mo-
lecular and cellular processes which may improve brain
function, structure and/or neural connectivity via several
pathways, including the release of various growth and
neurotrophic factors, and cognitive function, particularly
measures of executive functioning and processing speed
[25–29]. However, not all studies have reported benefi-
cial effects of exercise on measures of cognition, which
may relate to differences in the study populations, study
duration, training dose (duration, intensity and/or fre-
quency) and/or the dietary habits of individuals.
Previous research has shown that certain dietary pat-
terns or nutrients can have a positive effect on neuronal
plasticity and cognitive function among older adults
[30–33]. Although the data from randomised controlled
trials is limited, a number of reviews have highlighted
that the findings from epidemiologic studies tend to sup-
port a protective role of omega-3 fatty acids, B-vitamins
or antioxidants and the Mediterranean diet [30, 32, 33].
There is also emerging evidence that dietary protein and
its constituent amino acids are associated with cognitive
function in older adults [34–36]. In a population-based,
prospective study (median follow-up 3.7 years) in 937
elderly aged 70–89 years who were cognitively normal at
baseline, a higher dietary protein intake was associated
with a 21 % reduced risk of mild cognitive impairment
or dementia, independent of potential confounders [37].
While there are few intervention trials which have exam-
ined the effects of dietary protein or protein supplemen-
tation on cognition, a study in healthy young men
demonstrated that a high-protein meat diet for 3 weeks
improved cognitive function (reaction time for demand-
ing tasks) [38]. Moreover, an Australian study reported
that women habitually consuming less than the recom-
mended intake of red meat were twofold more likely to
experience depressive or anxiety disorders than those
consuming the recommended amount [39]. Given that
red meat contains other nutrients in addition to protein
such as iron, zinc, several B vitamins, omega-3 fatty
acids and possibly vitamin D which have all been linked
to cognitive function, we hypothesise that combining a
diet rich in red meat with PRT will be more effective for
enhancing cognitive function and neural plasticity in
older adults than PRT alone.
There are several lines of evidence to support our hy-
pothesis. One of the proposed mechanisms by which ex-
ercise may improve cognition and neural plasticity aswell as muscle health is via an increase in circulating
IGF-1 and serum brain-derived neurotrophic factor
(BDNF) and/or a reduction in systemic inflammation
[40, 41]. It is well known that IGF-1 is central to muscle
growth, but it has also been shown to have neuroprotec-
tive actions by promoting neuronal growth, survival and
differentiation [40, 42]. IGF-1 has also been shown to
augment BDNF concentrations, which is a neurotrophin
that functions to support the growth and maintenance
of neuronal circuits as we age [40]. Indeed, a number of
human studies have reported a link between circulating
BDNF concentrations and cognition [43, 44], and there
is evidence that BDNF stimulates neurons to survive
longer and branch and connect in new ways (synaptic
plasticity) to promote memory and learning [40, 45] as
well as executive function and processing speed [44, 46].
Finally, increased inflammation has also been linked to
muscle loss and cognitive impairment, and associated
with an increased risk of dementia [47, 48]. Building
upon our previous 4-month randomised controlled trial
in elderly women which showed that PRT combined
with increased consumption of lean red meat on most
days of the week resulted in a greater increase in serum
IGF-1 and a reduction in circulating IL-6 levels com-
pared to PRT alone, together with existing research
which has shown that dietary protein and exercise can
stimulate an increase in serum BDNF, we hypothesise
that combining these approaches will be more effective
at improving cognitive performance in older adults than
exercise alone. In addition, by measuring changes in cor-
tical plasticity using Transcranial Magnetic Stimulation
(TMS), a painless and non-invasive technique that al-
lows an assessment of neuroplasticity through cortical
excitability and inhibition (eg. responsiveness of the en-
tire neural pathway from the motor cortex to the
muscle), this study will provide new data on the role of
PRT combined with increased dietary protein on neural
plasticity in the elderly.
The primary aim of this 24-week randomised con-
trolled trial with a 24-week follow-up in community-
dwelling older adults is to examine the effects of a
multi-modal exercise program involving PRT combined
with a protein-enriched diet achieved through lean red
meat consumed three days per week (on training days)
on skeletal muscle mass, size and strength, and cognitive
function. The secondary aims of the study are to:
1. Evaluate the effects of the intervention on
physical functioning, neural plasticity
(corticospinal excitability and inhibition and
voluntary activation), various growth and
neurotrophic factors and systemic inflammatory
markers associated with muscle and cognitive
health, and health-related quality of life;
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cognitive function are modulated by body
composition, neurotrophic markers, inflammatory
cytokines, circulating growth factors, bioavailable
zinc and cardiovascular risk factors;
3. Determine if the 24-week supervised and structured
exercise and protein intervention can lead to long-
term behavioural changes with regard to maintaining
participation in exercise and/or consuming a diet
rich in red meat in older adults.Methods
Study design
This is a 48-week randomised controlled trial consisting of
a 24-week intervention with a 24-week follow-up. Men
and women aged 65 years and over will be randomly allo-
cated to one of two groups: 1) PRT with two 80g servings
of cooked lean red meat on each of the three days that
they complete their exercise session (RT+Meat group), or
2) control PRT in which participants will be provided with
and advised to consume ≥1 serving (~1/2 cup) of rice
and/or pasta or 1 medium potato on each of the three
training days [control resistance training (CRT)]. On the
non-training days, the red meat group will be instructed
to maintain their usual diet whilst those in the CRT group
will be asked to continue to incorporate larger servings of
breads, cereals, rice, pasta and vegetables (carbohydrates)
and smaller amounts of protein foods (e.g. meat, fish and
chicken). All participants will be asked to take a daily vita-
min D supplement (1000 IU) and encouraged to maintain
a healthy diet that includes the recommended amounts of
fruits and vegetables and dietary calcium throughout the
entire study. At the completion of the 24-week interven-
tion, all participants will be encouraged to continue to
undertake the exercise program (at their own expense)
and those in the red meat group were provided with
dietary advice to maintain a protein rich diet (at least
1.2 g/kg/day) including red meat which will be moni-
tored at weeks 36 and 48. The trial is managed by
the Centre for Physical Activity and Nutrition Re-
search at Deakin University, Burwood, Melbourne,
Australia and is funded by a nationally competitive
grant from Meat and Livestock Australia. The study
has been approved by the Deakin University Human
Research Ethics Committee (HREC 2013–166), and is
registered with the Australian and New Zealand
Clinical Trials Registry (ACTRN12613001153707).Participants
At least 152 community-dwelling men and women aged
65 years and over will be invited to participate in this
study.Recruitment
The intervention will be implemented across a number
of local community-based health and fitness centres
within Melbourne and surrounding areas in Victoria,
Australia. Recruitment and testing of participants will be
staggered and split into two cohorts over 2-years, each
starting at the same time of the year, to facilitate the
management and implementation of the trial. A variety
of recruitment strategies will be employed to attract par-
ticipants, including information talks at community cen-
tres, local media campaigns including newspaper and
magazine advertisements, flyers placed on relevant no-
tice boards and word of mouth. All participants that ex-
press an interest in being involved in the study will
undergo screening to determine their eligibility to par-
ticipate in the trial based on the criteria outlined below.
Screening and eligibility
Screening will consist of a four-step process. First, all par-
ticipants will be screened over the telephone and deemed
ineligible based on the following criteria: 1) aged <65 years;
2) current or prior participation in resistance exercise (>1
day per week) and/or moderate-intensity physical activity
≥150 minutes per week in the past 3 months; 3) acute or
terminal illness, including current (treated or untreated)
cancer or surgery/cessation of chemotherapy/radiotherapy
less than 12-months ago; 4) history of a recent low trauma
fracture with functional impairment that would limit par-
ticipation in the exercise program; 5) body mass index
(BMI) >40; 6) use of insulin to treat diabetes; 7) chronic
liver disease, coeliac or inflammatory bowel disease, includ-
ing ulcerative colitis or Crohn’s disease; 8) recent use of oral
corticosteroids (past 6 months); or 9) inability to commit to
the study and its requirements. Participants will not be ex-
cluded if they are currently taking vitamin D supplements,
but will be asked to take the vitamin D that is provided to
them as part of the study so that we are able to monitor
compliance. Second, eligible participants will then be asked
to complete the Short Portable Mental Status Question-
naire (SPMSQ) and the Geriatric Depression Scale (GDS)
to evaluate whether they are cognitively healthy and have
no signs of depression. Those with a score of greater than
two on the SPMSQ and/or a score of greater than six on
the GDS will be excluded from the study. For these partici-
pants, a letter will be sent to their doctor and they will be
encouraged to make an appointment with them to discuss
this is in further detail. Participants that remain eligible will
then be required to obtain approval from their local doctor
to clear them of any contraindicated medical conditions to
exercise, based upon American College of Sports Medicine
(ACSM) guidelines, to participate in the program. Finally,
participants will be asked to provide a fasted, morning
blood sample to confirm that their estimated Glomerular
Filtration Rate (eGFR) is >45 mL/min/1.73m2. Written
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prior to commencing the program.
Randomisation and blinding
Randomisation will be at the level of the individual par-
ticipant in blocks of four, stratified by gender, using a
computer-generated random number sequence by an in-
dependent researcher. Neither the participants nor re-
search staff involved in the testing will be blinded to the
allocation, but those analysing the data will be blinded.




All participants involved in the study will be prescribed
an individually tailored and supervised aerobic, PRT and
challenging balance and mobility program. All trainingFig. 1 Flow diagram of the progress from screening to the final follow-upwill be conducted at local community health and fitness
centres and participants will be asked to train on three
non-consecutive days per week for 24 weeks. Each train-
ing session will last approximately 60–75 minutes, and
include: a warm-up and cool-down, 15–20 minutes of
moderate intensity [5 to 8 (‘somewhat hard’ to ‘hard’) on
the 10 point Borg Rating of Perceived Exertion (RPE)
scale] aerobic training (e.g. cycling, treadmill walking,
stepping), at least two challenging balance/mobility and
postural exercises, and 30–40 minutes of moderate to
high intensity PRT. All exercise sessions will be super-
vised by qualified exercise trainers and will be conducted
in small groups where possible (approximately 6–8 per
group), but each participant’s program will be individua-
lised. For the first two weeks, participants will be asked
to complete three sets of 12–15 repetitions for each re-
sistance exercise using relatively moderate resistance to
familiarize themselves with the equipment (free andassessment
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execution of the exercises. Thereafter, participants will
be asked to complete three sets of 8–12 repetitions for
at least eight different upper and lower body exercises at
an intensity corresponding to 5 to 8 (‘somewhat hard’ to
‘hard’) on the 10 point Borg RPE scale. Some examples
of the exercises that will be used throughout the pro-
gram include: squats, lunges, box step-ups, leg exten-
sions, standing leg curls, hip abductions, calf raises,
shoulder press, upright row, bicep curls, wall push-ups,
and triceps kickbacks/pushdowns. Where possible, all
exercise sessions will be conducted prior to lunch or
dinner so that the participants can consume their pre-
scribed meal type as soon as possible following the train-
ing. If this is not possible, participants will be instructed
to consume one serve of red meat before training or
both serves after a training session.
Lean red meat
Participants allocated to the red meat group will be sup-
plied with ~220 g (raw weight) of lean red meat to be
consumed on each of the three training days per week
for 24 weeks to achieve a modest increase in mean diet-
ary protein intake in mean dietary protein intake to a
level of at least 1.3 g/kg/day. This equates to ~160 g of
cooked meat per day (~45 g of protein). All participants
will be asked to prepare the meals themselves and con-
sume the meat at lunch and dinner (~80 g cooked serv-
ing per meal) as there is emerging evidence that a
divided dose of protein spread throughout the day may
be more effective for enhancing muscle protein synthesis
than a single large dose in the evening [49]. The meat
will be supplied in labelled 110 g portion packs trimmed
of visible fat, and participants will select from a variety
of veal, lamb or beef cuts, delivered frozen every 4 weeks
by a local butcher. Participants living with a partner will
also receive sufficient food supplies for their partner. For
the other non-training days, participants will be advised
to maintain their usual diet. All participants will be pro-
vided with instructions of how to maintain a daily pro-
tein rich diet (e.g. foods and recipes rich in protein) and
will receive recipes and written dietary instructions for
consuming the red meat. We have found that this dietary
intervention in older women results in a modest average in-
crease in dietary protein from 1.1 to 1.3 g/kg/day [15]. We
therefore expect that participants will achieve an intake of
approximately 1.3 g/kg/day for 3 days/week when exercis-
ing and around 1.1 g/kg/day for the remaining 4 days.
Carbohydrate control
Participants randomized to the carbohydrate control
group will be instructed to consume their usual diet and
consume at least one serving per day of carbohydrates
(rice, potato and pasta) on each of the training days. Asall adults consume some carbohydrate foods every day
the provision of rice/pasta is provided to assist in keep-
ing the participants’ dietary protein intakes towards the
lower range of usual intake (<1.1 /kg/day) and to ensure
that both groups receive the same level of attention.
Participants in this group will be supplied with packs of
pasta and rice every 3 months, and advised to consume
at least one serving (~1/2 cup or ~125 ml) of cooked
rice or pasta or potato on the training days (~25–35g of
carbohydrates), and to focus on having larger servings of
bread, cereals, rice and vegetables and smaller serves of
protein foods (e.g. meat and fish). We have previously
found that the provision of some rice and pasta together
with this dietary advice results in no significant change in
mean dietary protein intake, which remained at 1.1 g/kg/
day in older women [15]. All participants will be provided
with recipes and written dietary instructions for consuming
a carbohydrate-rich diet and supplies for their partner
where appropriate.
Vitamin D
All participants will be asked to take one 1000 IU vita-
min D3 capsule (Ostelin, Australia) per day to try to en-
sure that serum 25-hydroxyvitamin D concentrations are
≥50 to 60 nmol/L for all participants, which is the
current recommended level for Australian adults [50].
Follow-up
At the completion of the 24-week supervised and struc-
tured intervention, all participants will be encouraged to
continue to participate in the exercise program (at their
own expense) and those in the red meat group will be
asked to continue to consume a protein-rich diet with at
least three servings of red meat per week. The primary
aim of the follow-up period is to document any long-
term behavioural changes with regard to maintaining
participation in regular exercise and consuming a diet
rich in red meat. All participants will be contacted via
the telephone at weeks 36 and 48 to assess their exercise
and dietary habits, using the similar methodology of 24
hr dietary recalls and a questionnaire specifically target-
ing the consumption of dietary protein including intake
of red meat over the defined period of time since last
contact.
Outcome measures
A summary of the primary and secondary outcomes and
other relevant covariates is shown in Table 1. All partici-
pants will be asked to attend Deakin University at base-
line and week 24 to undertake testing, with an
intermediary assessment of cognitive function conducted
on-site at each health and fitness centre at week 12.
With the exception of the fasted blood samples which
will be collected at local pathology clinics, and the
Table 1 Summary of the outcome measures
Variables Data collection method Data collection points (weeks)
Primary outcome measures Baseline Baseline 12 24 36 48
Muscle mass and cross-sectional area Dual energy X-ray absorptiometry (DXA) total body and regional
lean mass
x x
Peripheral quantitative computed tomography (pQCT) scan at 25%
femur site
x x
Muscle strength Leg press x x
Isometric knee extensor strength x x
Cognitive function Cogstate Brief Battery computerized tests x x x




Muscle Function Four-square step test x x
4 meter walk x x
30-second sit-to-stand test x x
Timed up and go test x x
Fat mass and inter-/intra-muscular fat DXA (total body and regional) and pQCT (25% femur site) x x
Biochemistry and hormonal measures Overnight fasted blood collection x x x
Neurotrophic markers Overnight fasted blood collection x x x
Adipokines and Inflammatory markers Overnight fasted blood collection x x x
Blood lipids Overnight fasted blood collection x x x
Bone mineral density DXA total body, hip and spine scan x x
Blood pressure Automated measurement x x
Health related Quality of Life Short form (SF)-36 version 2 questionnaire x x
Neural plasticity and voluntary activation Transcranial Magnetic Stimulation (TMS) * x x x
Additional Measures
Anthropometry Height, weight and body mass index (BMI) x x
Health and Lifestyle information Lifestyle Questionnaire x x
Habitual physical activity Community Healthy Activities Model Program for Seniors
questionnaire
x x x x
Memory and mood Memory Assessment Questionnaire (MAC-Q) x x
Depression and anxiety The Hospital Anxiety and Depression Scale (HADS)
questionnaire
x x
Diet 24-hour food diaries Monthly x x
Compliance to red meat and carbohydrates Food records Daily calendar
Vitamin D supplement compliance Pill count x
Compliance to exercise program Exercise cards Monthly
Adverse events Exercise cards and adverse events form Monthly
* TMS will also be assessed at week 4 and 8
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will be assessed within the Centre for Physical Activity
and Nutrition Research within the School of Exercise
and Nutrition Sciences at Deakin University, Burwood,
Melbourne, Australia.
Primary outcome measures
The primary outcome measures will be changes in total
body and regional (leg) lean tissue mass and musclecross-sectional area, muscle strength and cognitive
function.
Body Composition Dual energy x-ray absorptiometry
(DXA) will be used to assess total body and regional
(arms and legs) lean tissue mass, fat mass and percent-
age body fat (Lunar Prodigy, GE Lunar Corp., Madison
WI, software version 12.30.008). Muscle cross-sectional
area and muscle density, as a surrogate measure of
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will be assessed using peripheral quantitative computed
tomography (pQCT) (XCT 3000, Stratec Medizintechnik
GmbH, Pforzheim, Germany). As previously reported
[15], after performing a scout view of the distal end of
the femur, scans will be placed at the 4 % and 25 % pos-
ition of the femur. Slice thickness will be 2.3 mm, and
voxel size will be set at 0.3 mm with a scanning speed of
10 mm/s. Subcutaneous fat CSA will be determined by
selecting the area with thresholds –40 to +40 mg/cm3
HA density (contour mode 3, peel mode 1), and muscle
CSA will be determined by subtracting the total bone
CSA (threshold, 280 mg/cm3; contour mode 1, peel
mode 2) and subcutaneous fat CSA from the total area
of the distal femur (threshold, –40 mg/cm3, contour
mode 3, peel mode 1). The short-term co-efficient of
variation (CV) for repeated measurements of total body
lean mass and fat mass in our laboratory ranges from
1.0 % to 1.7 %. The CV for femur muscle CSA is 1.3 %.
Muscle strength Lower limb muscle strength will be
measured from the leg press machine using a three-
repetition maximum strength (3-RM) protocol. The 3-
RM is the heaviest weight that an individual can
complete three repetitions of an exercise whilst main-
taining correct form and technique, which corresponds
to ~85 % of an individual’s one repetition maximum
strength (1-RM). Prior to the assessment of each individ-
ual’s 3-RM leg press strength, they will be required to
complete a 5-minute warm-up on an exercise bike. To
determine 3-RM, each participant will perform a warm-
up set of 8-10 repetitions with a light to moderate load.
After the successful completion of a further 6–8 repeti-
tions at a heavier weight selected by the instructing re-
searcher and following a brief rest (~1–2 minutes), the
weight will be increased incrementally until only three
repetitions with correct technique can be completed. To
calculate 1-RM strength, the formula developed by
Wathen et al. [51] will be used. In addition to the leg
press, isometric knee extensor strength will be measured
on the participants’ dominant leg using Lord's strap as-
sembly incorporating a strain gauge (Neuroscience Re-
search Australia, Sydney, Australia). Participants will
have one practice trial followed by two maximal tests
with a 60 second rest between each test. This test has
been shown to have excellent test-retest reliability (Pear-
son r=0.92) [52]. For analysis, knee extension strength
(kg) will be expressed per unit of lower leg length to
compensate for the length of the lever arm.
Cognitive function The CogState Brief Battery comput-
erized tests (http://cogstate.com/) will be used to assess
cognitive function at baseline, 12 and 24 weeks. Briefly,
this is a multi-task computerised battery which providessensitive and valid measurement of a range of different
cognitive functions [53–55], including attention, pro-
cessing speed, memory and executive function. It is de-
signed to assess cognition over serial time points using a
computerised system that takes 30–40 minutes to
complete depending on the number of tests used. Im-
portantly, it has been specifically designed for repeated
administration over short time periods and has been val-
idated in older adults, with minimal practice or fatigue
effects, making it suited for detecting subtle change
[53–55]. For this study, participants will be asked to
complete five tasks from the CogState battery on a lap-
top with a mouse and headphones provided. Prior to
each test, participants will be given a verbal set of in-
structions, reinforcing the instructions written on the
screen. Participants will also be given a practice to en-
sure that they understand what is required for each test.
A brief description of the five tasks is provided below.
1. The Groton Maze Learning Task (GMLT) is a test of
executive function, memory and spatial problem
solving. In this test, participants will be exposed to a
10 x 10 grid of tiles on a computer screen, with a
28-step pathway hidden among the 100 possible lo-
cations. Participants will be required to find the hid-
den pathway (through trial and error feedback) that
extends from one corner of the grid to the other,
and remember (repeat) this pathway for four subse-
quent trials. The task is scored using the total num-
ber of errors made by the participant on five
consecutive trials at a single session. The lower the
score, the better their performance.
2. The Detection Task (DET) is a test of reaction time
measuring psychomotor function and speed of
processing. In this task, participants will be shown
the back of a playing card (patterned side) in the
centre of the screen and asked to respond to the
question “has the card turned over yet? As soon as
the card is flipped to the picture side, participants
will be required to press ‘yes’ on the keyboard as
quickly as possible. The task is completed after 35
correct trials have been recorded. This task is scored
using speed in milliseconds. The average reaction
times for correct responses will be used, normalised
using a log10 transformation.
3. The Identification Task (IDN) is a test of choice
reaction time measuring visual attention. For this
task, participants will be shown the back of a playing
card in the centre of the screen, and asked to
respond to the question ‘is the card red?” As soon as
the card is flipped to the picture side, the
participants have to decide as quickly as possible
whether the card is red or black. If the card is red,
participants will press the ‘yes’ key. If the card is
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after 30 correct responses have been recorded. The
task is scored using speed in milliseconds and mean
reaction times for correct responses. The average
will be normalised using a log10 transformation.
4. The One Card Learning Task (OCLT) is a test
assessing visual recognition memory and attention.
In this task, participants will be shown the back of a
playing card in the centre of the screen and asked to
respond to the question “have you seen this card
before in this task?” If the participant has seen the
card, they will be required to press the ‘yes’ key, or
the ‘no’ keys if they have not. In this task, six cards
are randomly drawn from the deck and repeated
throughout the task, and the first response will
always be ‘no’, as there has been no previous card
shown to the participant in the task. This task will
end after 88 trials, and is scored using the
proportion of correct responses, using an arcsine
square-root transformation to normalise the data.
5. The One-Back Working Memory Task (OBWMT) is
a test assessing working memory and attention. In
this task participants will be shown the back of a
playing card in the centre of the screen, and asked
to respond to the question “is this card the same as
that on the immediately previous trial?” If the
answer is yes participants will be required to press
the ‘yes’ key, or the ‘no’ key if the card is not the
same. The first response in this task is always ‘no’ as
there is no card prior to the first card. The task will
end after 30 correct responses have been recorded.
This test is scored using the proportion of correct
responses, using an arcsine square-root transform-
ation to normalise the data.
As previously reported [56], composite variables will
be created using each individual variable within a cogni-
tive domain. Scores will be transformed into a z-score
using the mean and standard deviation (SD) of the total
sample in the study and these z-scores will be averaged
across tests resulting in a single composite score for pro-
cessing speed/attention, memory and executive function
for each participant. Higher scores on these composites
indicate better performance and cognitive function.
Participants will also be required to complete a self-
report of executive function at baseline and week 24
using the Behaviour Rating of Inventory of Executive
Function-Adult Version (BRIEF-A). This is a self-report
measure comprised of 75 questions that make up nine
non-overlapping theoretically and empirically derived
clinical scales that provide a measure of various aspects
of executive functioning. These scales include: inhibit,
self-monitor, plan/organize, shift, initiate, task monitor,
emotional control, working memory, and organization ofmaterials [57]. For each question, a response of never,
sometimes or often will be recorded for how often in the
last month each behaviour listed had been a problem.
Each response corresponds to a number score of 1 to 4,
and these are summed to provide scores for each subdo-
main. The inhibit, shift and emotional control subdo-
mains are summed together to provide a behavioural
regulation index (BRI) score and the other subdomains
are summed to provide a metacognition index score
(MI) [57]. Lastly, the BRI and MI can be summed to
provide an overall global executive composite (GEC)
summary score [57].
Secondary outcome measures
Secondary outcome measures to be assessed at baseline
and week 24 (unless stated otherwise) will include:
changes in fat mass, muscle function, various circulating
biochemical, growth, inflammatory and neurotrophic
markers, bioavailable zinc, corticospinal excitability and
inhibition, blood pressure, blood lipids, memory, mood,
anxiety/depression, health-related quality of life and ad-
verse events. Other covariates and variables of interest
to be assessed include: anthropometry, habitual physical
activity, diet, alcohol intake and smoking status and
medication use. A summary of all the outcome measures
is shown in Table 1.
Biochemical, hormonal and inflammatory markers
All participants will be asked to attend one commercial
pathology clinic with multiple collection centres where a
fasted, morning (8–10am) venous blood sample will be
collected at baseline, 12 and 24 weeks. All blood will be
sent to a central laboratory that is a National Associ-
ation of Testing Authorities Royal College of Patholo-
gists Australasia accredited pathology laboratory. Serum
total cholesterol, high-density lipoprotein (HDL)-choles-
terol and triglycerides will be determined using an en-
zymatic colorimetric method (Roche Diagnostics,
Mannheim). Low density lipoprotein (LDL)-cholesterol
will be calculated by using Friedewald’s formula. High
sensitivity C-reactive protein (hs-CRP) will be measured
by an Immunoturbidimetric assay from Roche Diagnos-
tics, Mannheim. Serum creatinine, urea, albumin, cal-
cium, phosphorus, sodium, potassium and phosphorus
will be analysed by using standardized techniques. A 24-
hour urine sample will be collected and analysed for
urinary urea, creatinine, potassium and sodium using
standard techniques. Glomerular filtration rate (eGFR)
will be calculated using the participants’ serum creatin-
ine, age and gender in accordance with the appropriate
Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) formula as outlined by Johnson et al [58].
Serum aliquots will also be collected and stored at
–80 °C so that the following parameters can be
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study: serum IGF-1, 25-hydroxyvitamin D, homocyst-
eine, vitamin B12, folate, BDNF, vascular endothelial
growth factor (VEGF), adiponectin and a battery of
pro-inflammatory and anti-inflammatory cytokines,
including interleukin-6 (IL-6), interleukin-1 beta (IL-
1β), interleukin-8 (IL-8), tumor necrosis factor-alpha
(TNF-α) and interleukin-10 (IL-10). Serum bioavail-
able zinc will also be measured using flame atomic
absorption spectrophotometry by direct aspiration
(Varian SpectrAA-800).
Physical function Muscle performance will be assessed
using four validated tests.
The timed up-and-go test (TUG), which provides a
measure of dynamic balance during three commonly
performed functional activities: standing up from and
sitting down in a chair, walking, and turning [59]. For
this test, participants will be seated in a chair (height 45
cm) that will be placed at the end of a marked 3-metre
walkway and instructed to stand up, walk at a comfort-
able speed for 3 meters, turn back to the chair and sit
down. To minimise any ceiling effects and make the test
more challenging, participants will be instructed to start
counting backwards by 3’s from a random number. All
participants will be given a practice trial and one test
run. A stopwatch will be used to record the time taken
(in seconds) to complete the test.
The 4-metre walk test will be used to assess gait speed.
Participants will be required to walk in a straight line at
their normal walking speed across 4 metres. Participants
will begin walking 2 metres prior to and continue walk-
ing 2 metres past the 4 metre marker to ensure that a
measure of usual walking speed is measured. This test
will be recorded using timing gates (Swift Speedlink Per-
formance Equipment systems). Participants will be given
one practice trial before completing two test trials. The
fastest time (to the nearest millisecond) will be recorded.
The four-square step test (FSST) will be used to assess
dynamic standing balance and stepping speed in four
different directions [60]. For this test, participants will
be asked to step forward, sideways, and backwards over
four canes resting flat on the floor in a cross formation
as quickly as possible, moving first in a clockwise and
then counter-clockwise direction to return to the start-
ing position. After one practice trial, participants will
complete two test trials and the fastest time (in seconds)
taken to complete the sequence will be measured with a
stopwatch and recorded as the final score.
The 30-second sit-to-stand test (STS) is a measure of
lower-extremity muscle strength and function and is ad-
ministered in a chair without arms [61]. Participants
start from a seated position in the chair, with arms
folded across the chest, and are instructed to stand fullyupright and then return to the seated position at their
own pace as many times as possible in 30 seconds. The
final score will be the number of complete stands re-
corded during this time.
Measures of neural plasticity and voluntary activation
In a subset of approximately 30-40 participants, Trans-
cranial Magnetic Stimulation (TMS) will be used to
measure the functional properties of neurons confined
to the primary motor cortex and corticospinal pathway,
including corticospinal excitability, inhibition and volun-
tary activation. TMS is a non-invasive, painless and safe
technique that is used routinely to investigate the func-
tion of the nervous system with very low risk. In this
study, single and paired pulse TMS will be applied over
the left motor cortex using a BiStim unit attached to
two Magstim 2002 stimulators (Magstim, Dyfed, UK) to
produce motor evoked potentials (MEPs) in the domin-
ant (right) quadriceps. A double-cone coil will be placed
over the optimal site of the left primary cortex (sites
near the estimated centre of the rectus femoris - ap-
proximately 3–4 cm anterior from the vertex) to deter-
mine the optimal scalp position that produces the
largest MEP amplitude. To ensure all stimuli are deliv-
ered to the optimal motor hotspot throughout testing,
participants will wear a tightly fitted cap that is marked
with a latitude-longitude matrix, positioned with refer-
ence to the nasion-inion and interaural lines. All TMS
measures will be taken during weak muscle contraction,
where participants will be instructed to exert 20 % of
their pre-determined maximal voluntary torque (MVC
torque), as indicated by a visual line representing volun-
tary knee extension force on a computer monitor con-
nected to an isokinetic dynamometer (Biodex system 4
Pro, Biodex Medical Systems). The root mean square
(rms) of the rectus femoris sEMG will be obtained prior
to each TMS stimulus to ensure that there are no
changes in pre-stimulus rmsEMG prior to, and following
the intervention, which may artificially influence the
MEP amplitude. Active motor threshold (AMT) will be
determined as the minimum stimulus intensity required
to elicit a MEP in the right rectus femoris of at least 200
uV in three of five consecutive trials [62]. The stimulus
intensity will start at 50 % of maximum stimulator out-
put (MSO) and will be altered in increments of ±1 % of
MSO until the appropriate threshold level is achieved.
Single pulse input-output curves will be constructed
by stimulating the motor cortex from below each partici-
pant’s AMT and by increasing the stimulator intensity
by 10 % increments until MEP plateau. From the stimu-
lus response curve, the following parameters will be de-
termined: MEPMax or peak plateau, which provides an
estimate of the proportion of motoneuron pool that was
activated by TMS; slope steepness, which provides a
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cal and corticospinal connections, and half peak height
slope (V50), which provides a measure of the threshold
characteristics of corticospinal cells and alpha motoneu-
rons [63].
Using a paired-pulse technique, we will also measure
motor cortex inhibition [short-interval intracortical inhib-
ition (SICI) and long-interval intracortical inhibition
(LICI)], which provides a measure of suppression of neur-
onal firing mediated by γ-amino butyric acid (GABA) re-
ceptors [64]. To establish SICI, a conditioning stimulus
that is equal to 80 % of AMT will precede a supramaximal
test response that will be equal to 120 % of AMT. Each
pair of stimuli will be separated by a 3 millisecond inter-
stimulus interval [65]. Similarly, to establish LICI, two
supramaximal test responses set at 120 % AMT will be ap-
plied to the motor cortex, with each pair of stimuli sepa-
rated by a 150 millisecond interstimulus interval [66].
Since TMS evokes a muscle twitch as a result of supra-
maximal stimulation, we will also measure the TMS-
evoked twitch force to determine cortical voluntary activa-
tion, which provides a measure of the net motor output
from the motor cortex to the muscle, as previously de-
scribed [67]. To establish any changes in cortical voluntary
activation, participants will be instructed to match a re-
quired force (20 %, 50 %, 75 % and 100 % maximum vol-
untary contraction) using a horizontal line on a computer
screen as visual feedback. During each contraction, TMS
will be delivered over the left hemisphere at a stimulus in-
tensity that elicits the largest MEP to evoke superimposed
twitches. Cortical voluntary activation will then be calcu-
lated using a linear regression as described by Carroll [67].
In order to identify any potential changes in the excit-
ability of the spinal motor neuron pool, maximal electrical
responses (M-waves) will be recorded by direct electrical
stimulation of the femoral nerve under resting conditions.
A Digitimer (Hertfordshire, UK) DS7A constant-current
electrical stimulator (pulse duration 1 ms) will be used to
deliver each electrical pulse. An increase in current
strength will be applied to the femoral nerve until there is
no further increase in the amplitude of surface electro-
myography (sEMG) activity response (MMAX) [62].
All MEPs will be recorded via sEMG activity from the
right rectus femoris muscle using bipolar Ag–AgCl elec-
trodes. These electrodes will placed on the rectus
femoris, three-fifths of the distance between the anterior
superior iliac spine and the upper border of the patella,
with an inter-electrode distance (centre to centre) of 20
mm [65]. The reference electrode will be placed on the
patella to ensure no muscle activity is recorded. All ca-
bles will be fastened with tape to prevent movement
artefact. The area of electrode placement will be shaven
to remove fine hair, rubbed with an abrasive rasp to re-
move dead skin, and then cleaned with 70 % isopropylalcohol. sEMG signals will be amplified (1000×), band-
pass filtered (high pass at 13 Hz, low pass at 1000 Hz),
digitized online at 2 kHz, recorded and analyzed using
PowerLab 4/35.
Blood pressure Systolic and diastolic blood pressure
will be measured using an automated blood pressure
monitor (A&D Instruments, Oxon, UK) after a 5-minute
rest period seated in a quiet room. A total of four mea-
surements will be taken with a 2-minute interval be-
tween readings; the mean of the final three readings will
be used in the analysis.
Health-related quality of life Health-related quality of
life (QoL) will be assessed using the Short-Form (SF)-36
(version 2) questionnaire, with permission from the
Medical Outcomes Trust (Boston, MA, USA), and re-
ported using Australian norm-based scores according to
previously published guidelines [68, 69]. From the 36
items, scores will be calculated for the following eight
domains: physical functioning, role-physical, bodily pain,
general health, vitality, social functioning, role-emotional
and mental health [69]. The data will be normalised to
reported data from the 2004 South Australian Health
Omnibus survey to allow for appropriate and meaningful
comparisons for changes in scores across the eight do-
mains and summary scores [68]. This will allow for the
changes in domains to be assessed meaningfully and will
account for cultural differences in various populations in
regard to the meaning of QoL. Summary measures of
the physical and mental components of the survey will
be calculated based on a factor analysis of the eight do-
mains among participants in the 2004 South Australian
Health Omnibus Survey, resulting in two separate over-
all summary scores: the physical component summary
(PCS) and the mental component summary (MCS)
scores [68]. The use of norm-based weights gives each
domain score a mean of 50 and a standard deviation
(SD) of 10, allowing change in scores to be assessed on a
comparable scale.
Additional measures
Memory, depression and anxiety The Memory Assess-
ment Questionnaire (MAC-Q) [70] will be used as a
measure of subjective memory complaint severity. This
tool comprises six questions related to memory func-
tioning in everyday situations in which the participants
are asked to compare and rate their current ability com-
pared to when they were aged 40. The total score on the
MAC-Q ranges from 7 to 35, where greater scores indi-
cate subjective memory loss. Scores greater than or
equal to 25 have been found to be suggestive of age-
associated memory impairment.
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questionnaire will be used to measure psychological
functioning (anxiety and depression) [71]. The HADS
questionnaire is a self-report rating scale consisting of
14 items on a four-point likert scale (range: 0-3 where a
higher score represents more severe depression or anx-
iety), which includes seven questions evaluating cogni-
tive and emotional aspects of anxiety, and seven
questions assessing the cognitive and emotional aspects
of depression. The results will be reported as the sum of
all 14 items, and the sum for each of the two subscales
of seven items.
Dietary habits Dietary habits will be assessed from two
24-hour dietary diaries completed by the participants on
two consecutive days at baseline and at weeks 4, 8, 12, 16,
20 and 24 and then again at weeks 36 and 48. Participants
in the lean red meat group will complete one 24-hour
food diary on a day that they consume their red meat and
the other 24-hour food diary on a day that they do not
consume red meat as part of the intervention. Participants
will be required to provide as much detail as possible re-
garding brand names, cooking methods and recipes for
foods and beverages consumed in the past 24 hours.
Household measures including measuring cups, plates,
bowls and glasses will be used to assist in estimating food
portion sizes. Information from these diet history diaries
will be checked by the research staff and used to assess
total energy and nutrient intakes using Foodworks 7
(Foodworks, Xyris Software, Highgate Hill, Australia).
Anthropometry Height will be measured to the nearest
0.1 cm with a wall-mounted stadiometer and bodyweight
to the nearest 0.1 kg using calibrated electronic digital
scales.
Physical activity The Community Healthy Activities
Model Program for Seniors (CHAMPS) physical activity
questionnaire will be used to assess total leisure and rec-
reational physical activity time. This questionnaire has
been specifically designed for use in older adults and
found to be reliable, valid and sensitive to change [72].
Participants will document their weekly frequency and
duration of participation in a ‘typical week’ of the pre-
ceding four weeks. The results will be reported as hours
per week and, estimated kilojoules per week spent in
moderate to high intensity activities.
Health and medical history and medication use A
lifestyle questionnaire will be used to obtain informa-
tion on education background, history of disease(s)/ill-
nesses, falls and fractures, smoking history, current use
of medication and dietary supplement use, average
weekly alcohol consumption, and weekly televisionviewing and sitting time, and sun exposure habits. In-
formation on any alterations to, or new, medication
prescribed by the participants’ doctor during the study
will also be collected by research staff via the monthly
phone calls. Information including medication name,
dose prescribed, and daily quantity taken will be
recorded.
Compliance Exercise cards completed by the partici-
pants and monitored by the exercise trainers will be
used to monitor adherence to the exercise program.
Moreover, at each training session the exercise trainers
will document attendance/non-attendance for each par-
ticipant, and will contact the research staff if participants
miss multiple sessions consecutively. The exercise cards
will be collected by the research staff from each health
and fitness centre at approximately monthly intervals
throughout the intervention for review. To monitor the
consumption of lean red meat, participants will be asked
to record all meat products consumed (from that sup-
plied by the investigators) on a compliance calendar,
which will be collected every month. Participants in the
carbohydrate control group will also be asked to
complete a checklist of carbohydrate-rich meals (pasta
and rice) on a daily calendar. Compliance with the vita-
min D supplements will be checked by counting
returned tablets at after 6 months.
Adverse events At the end of each 4-week period, par-
ticipants will be required to document any exercise-
related adverse events including any injuries related to
the exercise program. An adverse event will be defined
as an intervention-related event resulting in absence
from, or modification to, the exercise program. All
exercise-related adverse events forms will be collected
monthly so that the researchers can follow-up on any
adverse events. Diet-related adverse events (interven-
tion-related events resulting in modification of dietary
instructions) will be collected via a telephone adminis-
tered questionnaire every 8-weeks.
Sample size calculations
The number of participants required for this study is
based on power calculations for the expected changes in
total body lean mass, lower limb muscle strength and
cognitive function, particularly executive function. Based
on our previous study in elderly women [15], we estimate
that 152 older adults in each group will provide >80 %
power (P<0.05, two tailed) to detect a 0.5 kg and 18 % dif-
ferences for the change in total body lean mass and leg
muscle strength between the red meat and control group,
assuming a standard deviation of 0.9 kg and 30 %, respect-
ively. This calculation allows for a possible 20 % drop-out
or loss to follow-up. For measures of cognitive function, it
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tude of any intervention effect (effect size) because this
study is the first to examine the effects of exercise com-
bined with increased dietary protein compared to exercise
alone in older adults. Previous research examining the ef-
fects of exercise on measures of cognitive function report
moderate effect sizes (d = 0.41 to 0.59) following PRT or
aerobic training alone or in combination [25, 26, 73], par-
ticularly on measures of executive function and processing
speed. Whether increased dietary protein can improve
cognitive function in older adults remains uncertain, but
we hypothesize that exercise combined with a modest in-
crease in dietary protein (1.3 g/kg/day) will lead to a
medium effect. Using data from a pilot study in 72 healthy
older adults aged 65 years and over in which the mean
(standard deviation, SD) scores on the CogState Groton
Maze Learning Task (a measure of executive function) and
the Detection Task (a measure of reaction time and pro-
cessing speed) were 64 (18) and 2.56 (0.07) respectively, we
anticipate that a sample size of at least 140 will provide ap-
proximately 80 % power (P<0.05, two-tailed) to determine a
medium effect size (f = 0.20) assuming a 0.6 correlation
among repeated measures.
Statistical analyses
The primary statistical analysis will be conducted on an
intention-to-treat basis using STATA statistical software
release 13.0 (STATA, College Station, TX, USA). For
participants with at least 66 % compliance to the exer-
cise program (two out of three sessions per week) and
80 % compliance with the lean red meat, per protocol
analyses will also be performed. Descriptive statistics will
be used to compare the background variables and base-
line measures between the groups, and any imbalances
will be adjusted for during subsequent analyses. Wher-
ever possible, we will obtain endpoint measures from all
withdrawals and include all randomised participants in
our final data analysis. Any missing data for participants
that are lost to follow-up will be handled with multiple
imputation, but sensitivity analysis will be conducted to
evaluate the effect of potential non-random attrition. All
data will be checked for normality prior to analysis, and
data that is skewed will be log transformed prior to
analysis. Baseline measures and changes in outcome
variables will be presented as means ± SD or 95 % confi-
dence intervals. The effects of the intervention will be
assessed using linear mixed models with random effects.
Subsequent adjusted analysis for potential covariates (age,
sex, race/ethnicity, cardiovascular disease risk, depression/
anxiety, changes in medication and change in habitual
physical activity or diet) will also be conducted. Multiple
regression analysis will be used to investigate whether
body composition, circulating neurotrophic, growth or in-
flammatory markers, bioavailable zinc and cardiovascularrisk factors are associated with changes in cognitive func-
tion. The significance level will be set at P<0.05 or smaller
if adjustments are made for multiple comparisons.
Discussion
This community-based RCT will be the first to evaluate
whether a multi-modal exercise program incorporating
PRT in combination with increased dietary protein
achieved through the consumption of two ~80 g serv-
ings of cooked lean red meat on each of the three train-
ing days is a safe and effective strategy to enhance
muscle mass, size and strength and cognitive function in
community-dwelling older adults. In addition, this study
will determine whether such an intervention translates
into long-term behavioural changes with regard to
adopting a healthier lifestyle that incorporates regular
participation in PRT and consumption of a diet high in
protein (red meat). This is important because age-
related muscle wasting and a decline in cognitive func-
tion have both been implicated in the development and
progression of many chronic diseases, including falls and
dementia. From a public health perspective, if the inter-
vention proves to be effective, the pragmatic nature of
the intervention, with the exercise conducted within
local community-based health and fitness centres and
dietary protein increased through the use of lean red
meat at an intake equivalent to the current Australian
dietary guidelines of 3–4 serves per week, should ensure
that the program can be easily implemented and
adopted and is applicable in real life.
Another strength of the study is that our secondary
outcomes will provide a unique opportunity to: 1)
evaluate the effects of the intervention on neural
plasticity, and 2) identify potential biological determi-
nants of exercise and protein-induced changes in cog-
nitive function (and skeletal muscle health) in older
adults. Specifically, this study will be one of the first
to determine whether combining exercise with in-
creased dietary protein (lean red meat) can have a
positive effect on a range of neurobiological markers,
including various circulating growth and neurotrophic
factors (e.g., IGF-1, BDNF, VEGF) and systemic in-
flammatory cytokines in older adults, and whether
any changes in these biological determinants in re-
sponse to the intervention are associated with any
changes in cognitive function and neural plasticity.
In summary, we believe that the findings from this
study will form the basis for more targeted nutrition
and exercise guidelines for the management and pre-
vention of age-related changes in muscle and neural
health as well as cognitive function in older people.
We anticipate that the findings from this study will
provide direct evidence that the current guidelines to
consume no more than 455 g of lean red meat is a
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tein that can have beneficial effects on improving
multiple health outcomes when combined with regu-
lar exercise. In addition, we expect that the results
will also show that there are no adverse effect of this
approach on cardiovascular-related health outcomes
or kidney function. This is important because there
are some concerns that a high red meat diet is asso-
ciated with a number of adverse health outcomes, in-
cluding an increased risk of heart disease, type 2
diabetes and certain cancers.
Trial status
Recruitment is currently underway and a number of par-
ticipants have commenced the study.
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